Magnetic Resonance Elastography for Liver Fibrosis in Methotrexate Treatment.

about

Magnetic resonance elastography of liver: clinical applications.Diagnostic performance of transient elastography for detection of methotrexate-induced liver injury using Roenigk classification in Asian patients with psoriasis: a retrospective study.

P2860

Q30435917-E80FC899-E653-4ECB-BFA1-9E76288AD3D5 Q38902243-9786D987-52F7-46DF-A91C-ACAD92EA4562

P2860

Magnetic Resonance Elastography for Liver Fibrosis in Methotrexate Treatment.

Item

http://www.wikidata.org/entity/Q36036715

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Magnetic Resonance Elastography for Liver Fibrosis in Methotrexate Treatment.

@ast

Magnetic Resonance Elastography for Liver Fibrosis in Methotrexate Treatment.

@en

type

Item

label

Magnetic Resonance Elastography for Liver Fibrosis in Methotrexate Treatment.

@ast

Magnetic Resonance Elastography for Liver Fibrosis in Methotrexate Treatment.

@en

prefLabel

Magnetic Resonance Elastography for Liver Fibrosis in Methotrexate Treatment.

@ast

Magnetic Resonance Elastography for Liver Fibrosis in Methotrexate Treatment.

@en

P1476

Magnetic Resonance Elastography for Liver Fibrosis in Methotrexate Treatment.

@en

P2093

Clement J Michet

http://www.w3.org/2001/XMLSchema#string

Cynthia S Crowson

http://www.w3.org/2001/XMLSchema#string

Deana D Hoganson

http://www.w3.org/2001/XMLSchema#string

Eric L Matteson

http://www.w3.org/2001/XMLSchema#string

Jayant A Talwalkar

http://www.w3.org/2001/XMLSchema#string

Jun Chen

http://www.w3.org/2001/XMLSchema#string

Meng Yin

http://www.w3.org/2001/XMLSchema#string

Richard L Ehman

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical liver disease in patients with rheumatoid arthritis taking methotrexate

Methotrexate and histologic hepatic abnormalities: a meta-analysis

Liver histology in patients receiving low dose pulse methotrexate for the treatment of rheumatoid arthritis.

Nonalcoholic fatty liver disease

Assessment of hepatic fibrosis with magnetic resonance elastography.

Risk factors for methotrexate-induced abnormal laboratory monitoring results in patients with rheumatoid arthritis.

Two methods of assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis.

Methotrexate hepatotoxicity.

Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference.

Long term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely the result of laboratory abnormalities.

P304

6-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4236/OJRA.2012.22003

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26361561

http://www.w3.org/2001/XMLSchema#string

P932

4562680

http://www.w3.org/2001/XMLSchema#string

Magnetic Resonance Elastography for Liver Fibrosis in Methotrexate Treatment.

about

P2860

P2860

Magnetic Resonance Elastography for Liver Fibrosis in Methotrexate Treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932